nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—Semen abnormal—Varenicline—nicotine dependence	0.12	0.166	CcSEcCtD
Doxazosin—Semen analysis abnormal—Varenicline—nicotine dependence	0.12	0.166	CcSEcCtD
Doxazosin—ORM1—saliva—nicotine dependence	0.0289	0.385	CbGeAlD
Doxazosin—Myopia—Varenicline—nicotine dependence	0.0263	0.0364	CcSEcCtD
Doxazosin—Peripheral ischaemia—Varenicline—nicotine dependence	0.0157	0.0218	CcSEcCtD
Doxazosin—Urine abnormality—Varenicline—nicotine dependence	0.0104	0.0144	CcSEcCtD
Doxazosin—Sexual dysfunction—Varenicline—nicotine dependence	0.0102	0.0142	CcSEcCtD
Doxazosin—Gastric ulcer—Varenicline—nicotine dependence	0.00987	0.0137	CcSEcCtD
Doxazosin—Urine analysis abnormal—Varenicline—nicotine dependence	0.00976	0.0135	CcSEcCtD
Doxazosin—Psoriasis—Varenicline—nicotine dependence	0.00913	0.0126	CcSEcCtD
Doxazosin—Parosmia—Varenicline—nicotine dependence	0.00885	0.0123	CcSEcCtD
Doxazosin—KCNH7—brain—nicotine dependence	0.00881	0.117	CbGeAlD
Doxazosin—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.00876	0.0121	CcSEcCtD
Doxazosin—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00789	0.0389	CbGpPWpGaD
Doxazosin—Scotoma—Varenicline—nicotine dependence	0.00756	0.0105	CcSEcCtD
Doxazosin—Fungal infection—Varenicline—nicotine dependence	0.00743	0.0103	CcSEcCtD
Doxazosin—Gingivitis—Varenicline—nicotine dependence	0.00731	0.0101	CcSEcCtD
Doxazosin—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00725	0.0358	CbGpPWpGaD
Doxazosin—Nephrolithiasis—Varenicline—nicotine dependence	0.00714	0.00988	CcSEcCtD
Doxazosin—Disturbance in attention—Varenicline—nicotine dependence	0.00662	0.00917	CcSEcCtD
Doxazosin—KCNH6—Neuronal System—CHRNB3—nicotine dependence	0.00657	0.0324	CbGpPWpGaD
Doxazosin—Viral infection—Varenicline—nicotine dependence	0.00635	0.0088	CcSEcCtD
Doxazosin—KCNH6—brain—nicotine dependence	0.00627	0.0836	CbGeAlD
Doxazosin—Thinking abnormal—Varenicline—nicotine dependence	0.00627	0.00868	CcSEcCtD
Doxazosin—KCNH6—Neuronal System—CHRNA6—nicotine dependence	0.00623	0.0307	CbGpPWpGaD
Doxazosin—Nocturia—Varenicline—nicotine dependence	0.00619	0.00857	CcSEcCtD
Doxazosin—KCNH7—Neuronal System—CHRNB3—nicotine dependence	0.00586	0.0289	CbGpPWpGaD
Doxazosin—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00566	0.0279	CbGpPWpGaD
Doxazosin—Influenza like illness—Varenicline—nicotine dependence	0.00557	0.00772	CcSEcCtD
Doxazosin—KCNH7—Neuronal System—CHRNA6—nicotine dependence	0.00555	0.0274	CbGpPWpGaD
Doxazosin—Nightmare—Varenicline—nicotine dependence	0.00554	0.00767	CcSEcCtD
Doxazosin—Photophobia—Varenicline—nicotine dependence	0.00539	0.00746	CcSEcCtD
Doxazosin—Oesophagitis—Varenicline—nicotine dependence	0.00524	0.00726	CcSEcCtD
Doxazosin—Urine output increased—Varenicline—nicotine dependence	0.00519	0.00718	CcSEcCtD
Doxazosin—Hypertonia—Varenicline—nicotine dependence	0.00503	0.00696	CcSEcCtD
Doxazosin—Mental disability—Varenicline—nicotine dependence	0.00498	0.0069	CcSEcCtD
Doxazosin—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00489	0.0241	CbGpPWpGaD
Doxazosin—Lymphadenopathy—Varenicline—nicotine dependence	0.00488	0.00676	CcSEcCtD
Doxazosin—Polyuria—Varenicline—nicotine dependence	0.00474	0.00657	CcSEcCtD
Doxazosin—Deafness—Varenicline—nicotine dependence	0.00466	0.00645	CcSEcCtD
Doxazosin—Eczema—Varenicline—nicotine dependence	0.00463	0.00642	CcSEcCtD
Doxazosin—Eye pain—Varenicline—nicotine dependence	0.00461	0.00639	CcSEcCtD
Doxazosin—KCNH6—Neuronal System—GABRA4—nicotine dependence	0.0045	0.0222	CbGpPWpGaD
Doxazosin—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.0045	0.0222	CbGpPWpGaD
Doxazosin—Libido decreased—Varenicline—nicotine dependence	0.00449	0.00622	CcSEcCtD
Doxazosin—Hot flush—Varenicline—nicotine dependence	0.00445	0.00617	CcSEcCtD
Doxazosin—Increased appetite—Varenicline—nicotine dependence	0.00443	0.00614	CcSEcCtD
Doxazosin—Amnesia—Varenicline—nicotine dependence	0.00443	0.00614	CcSEcCtD
Doxazosin—Menopausal symptoms—Varenicline—nicotine dependence	0.00441	0.00611	CcSEcCtD
Doxazosin—Atrial fibrillation—Varenicline—nicotine dependence	0.0044	0.00609	CcSEcCtD
Doxazosin—Thirst—Varenicline—nicotine dependence	0.00438	0.00606	CcSEcCtD
Doxazosin—KCNH6—Neuronal System—CHRNB4—nicotine dependence	0.00432	0.0213	CbGpPWpGaD
Doxazosin—Arthritis—Varenicline—nicotine dependence	0.00429	0.00593	CcSEcCtD
Doxazosin—ADRA1D—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.00426	0.021	CbGpPWpGaD
Doxazosin—Cerebrovascular accident—Varenicline—nicotine dependence	0.00425	0.00589	CcSEcCtD
Doxazosin—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00417	0.00577	CcSEcCtD
Doxazosin—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00413	0.00572	CcSEcCtD
Doxazosin—Affect lability—Varenicline—nicotine dependence	0.0041	0.00568	CcSEcCtD
Doxazosin—Migraine—Varenicline—nicotine dependence	0.0041	0.00568	CcSEcCtD
Doxazosin—ADRA1A—cardiovascular system—nicotine dependence	0.00407	0.0542	CbGeAlD
Doxazosin—KCNH6—Neuronal System—CHRNA5—nicotine dependence	0.00401	0.0198	CbGpPWpGaD
Doxazosin—KCNH7—Neuronal System—GABRA4—nicotine dependence	0.00401	0.0198	CbGpPWpGaD
Doxazosin—Urinary retention—Varenicline—nicotine dependence	0.00396	0.00548	CcSEcCtD
Doxazosin—Mood swings—Varenicline—nicotine dependence	0.00395	0.00546	CcSEcCtD
Doxazosin—KCNH2—cardiovascular system—nicotine dependence	0.00393	0.0523	CbGeAlD
Doxazosin—KCNH7—Neuronal System—CHRNB4—nicotine dependence	0.00385	0.019	CbGpPWpGaD
Doxazosin—Liver function test abnormal—Varenicline—nicotine dependence	0.00385	0.00533	CcSEcCtD
Doxazosin—Dry skin—Varenicline—nicotine dependence	0.00382	0.00529	CcSEcCtD
Doxazosin—Hypokalaemia—Varenicline—nicotine dependence	0.00379	0.00525	CcSEcCtD
Doxazosin—Cramp muscle—Varenicline—nicotine dependence	0.00375	0.00519	CcSEcCtD
Doxazosin—Abdominal distension—Varenicline—nicotine dependence	0.00362	0.00502	CcSEcCtD
Doxazosin—KCNH7—Neuronal System—CHRNA5—nicotine dependence	0.00358	0.0176	CbGpPWpGaD
Doxazosin—ADRA1B—brain—nicotine dependence	0.00355	0.0473	CbGeAlD
Doxazosin—ADRA1B—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.00354	0.0174	CbGpPWpGaD
Doxazosin—Angina pectoris—Varenicline—nicotine dependence	0.00351	0.00486	CcSEcCtD
Doxazosin—ADRA1D—brain—nicotine dependence	0.00348	0.0463	CbGeAlD
Doxazosin—Bronchitis—Varenicline—nicotine dependence	0.00346	0.00479	CcSEcCtD
Doxazosin—Abdominal discomfort—Varenicline—nicotine dependence	0.00345	0.00478	CcSEcCtD
Doxazosin—KCNH7—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00334	0.0165	CbGpPWpGaD
Doxazosin—Pollakiuria—Varenicline—nicotine dependence	0.00333	0.00461	CcSEcCtD
Doxazosin—Erectile dysfunction—Varenicline—nicotine dependence	0.00332	0.00459	CcSEcCtD
Doxazosin—Photosensitivity reaction—Varenicline—nicotine dependence	0.00329	0.00455	CcSEcCtD
Doxazosin—Weight increased—Varenicline—nicotine dependence	0.00328	0.00454	CcSEcCtD
Doxazosin—KCNH6—Neuronal System—CHRNA3—nicotine dependence	0.00327	0.0161	CbGpPWpGaD
Doxazosin—Hyperglycaemia—Varenicline—nicotine dependence	0.00325	0.0045	CcSEcCtD
Doxazosin—Depression—Varenicline—nicotine dependence	0.0032	0.00443	CcSEcCtD
Doxazosin—ADRA1D—Monoamine GPCRs—DRD2—nicotine dependence	0.00319	0.0157	CbGpPWpGaD
Doxazosin—Acute coronary syndrome—Varenicline—nicotine dependence	0.00316	0.00438	CcSEcCtD
Doxazosin—Myocardial infarction—Varenicline—nicotine dependence	0.00315	0.00436	CcSEcCtD
Doxazosin—ADRA1A—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.00314	0.0155	CbGpPWpGaD
Doxazosin—Conjunctivitis—Varenicline—nicotine dependence	0.00312	0.00432	CcSEcCtD
Doxazosin—KCNH2—midbrain—nicotine dependence	0.00307	0.0409	CbGeAlD
Doxazosin—Epistaxis—Varenicline—nicotine dependence	0.00303	0.00419	CcSEcCtD
Doxazosin—Sinusitis—Varenicline—nicotine dependence	0.00301	0.00417	CcSEcCtD
Doxazosin—Bradycardia—Varenicline—nicotine dependence	0.00293	0.00406	CcSEcCtD
Doxazosin—KCNH7—Neuronal System—CHRNA3—nicotine dependence	0.00292	0.0144	CbGpPWpGaD
Doxazosin—KCNH6—Neuronal System—CHRNB2—nicotine dependence	0.00288	0.0142	CbGpPWpGaD
Doxazosin—Hypoaesthesia—Varenicline—nicotine dependence	0.00287	0.00397	CcSEcCtD
Doxazosin—Visual impairment—Varenicline—nicotine dependence	0.00278	0.00385	CcSEcCtD
Doxazosin—Eye disorder—Varenicline—nicotine dependence	0.00269	0.00373	CcSEcCtD
Doxazosin—Tinnitus—Varenicline—nicotine dependence	0.00269	0.00372	CcSEcCtD
Doxazosin—ADRA1D—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00268	0.0132	CbGpPWpGaD
Doxazosin—ADRA1B—Monoamine GPCRs—DRD2—nicotine dependence	0.00265	0.0131	CbGpPWpGaD
Doxazosin—KCNH6—Neuronal System—CHRNA4—nicotine dependence	0.00262	0.0129	CbGpPWpGaD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00259	0.0128	CbGpPWpGaD
Doxazosin—Chills—Varenicline—nicotine dependence	0.00259	0.00358	CcSEcCtD
Doxazosin—Arrhythmia—Varenicline—nicotine dependence	0.00257	0.00356	CcSEcCtD
Doxazosin—KCNH7—Neuronal System—CHRNB2—nicotine dependence	0.00257	0.0127	CbGpPWpGaD
Doxazosin—Mental disorder—Varenicline—nicotine dependence	0.00252	0.0035	CcSEcCtD
Doxazosin—Malnutrition—Varenicline—nicotine dependence	0.00251	0.00347	CcSEcCtD
Doxazosin—KCNH2—Neuronal System—CHRNB3—nicotine dependence	0.00248	0.0122	CbGpPWpGaD
Doxazosin—Flatulence—Varenicline—nicotine dependence	0.00247	0.00342	CcSEcCtD
Doxazosin—KCNH7—Circadian rythm related genes—DRD2—nicotine dependence	0.00247	0.0122	CbGpPWpGaD
Doxazosin—Dysgeusia—Varenicline—nicotine dependence	0.00246	0.0034	CcSEcCtD
Doxazosin—Back pain—Varenicline—nicotine dependence	0.00243	0.00336	CcSEcCtD
Doxazosin—ADRA2A—midbrain—nicotine dependence	0.00242	0.0322	CbGeAlD
Doxazosin—Muscle spasms—Varenicline—nicotine dependence	0.00241	0.00334	CcSEcCtD
Doxazosin—Vision blurred—Varenicline—nicotine dependence	0.00236	0.00327	CcSEcCtD
Doxazosin—ADRA1A—Monoamine GPCRs—DRD2—nicotine dependence	0.00235	0.0116	CbGpPWpGaD
Doxazosin—KCNH2—Neuronal System—CHRNA6—nicotine dependence	0.00235	0.0116	CbGpPWpGaD
Doxazosin—Tremor—Varenicline—nicotine dependence	0.00235	0.00325	CcSEcCtD
Doxazosin—KCNH7—Neuronal System—CHRNA4—nicotine dependence	0.00233	0.0115	CbGpPWpGaD
Doxazosin—Ill-defined disorder—Varenicline—nicotine dependence	0.00233	0.00322	CcSEcCtD
Doxazosin—Agitation—Varenicline—nicotine dependence	0.00231	0.00319	CcSEcCtD
Doxazosin—Malaise—Varenicline—nicotine dependence	0.00226	0.00313	CcSEcCtD
Doxazosin—Vertigo—Varenicline—nicotine dependence	0.00225	0.00312	CcSEcCtD
Doxazosin—Syncope—Varenicline—nicotine dependence	0.00225	0.00311	CcSEcCtD
Doxazosin—ADRA1B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00223	0.011	CbGpPWpGaD
Doxazosin—Palpitations—Varenicline—nicotine dependence	0.00222	0.00307	CcSEcCtD
Doxazosin—Loss of consciousness—Varenicline—nicotine dependence	0.0022	0.00305	CcSEcCtD
Doxazosin—Cough—Varenicline—nicotine dependence	0.00219	0.00303	CcSEcCtD
Doxazosin—ADRA2A—Monoamine GPCRs—DRD2—nicotine dependence	0.00219	0.0108	CbGpPWpGaD
Doxazosin—Convulsion—Varenicline—nicotine dependence	0.00217	0.00301	CcSEcCtD
Doxazosin—Hypertension—Varenicline—nicotine dependence	0.00217	0.003	CcSEcCtD
Doxazosin—Arthralgia—Varenicline—nicotine dependence	0.00214	0.00296	CcSEcCtD
Doxazosin—Chest pain—Varenicline—nicotine dependence	0.00214	0.00296	CcSEcCtD
Doxazosin—Myalgia—Varenicline—nicotine dependence	0.00214	0.00296	CcSEcCtD
Doxazosin—Anxiety—Varenicline—nicotine dependence	0.00213	0.00295	CcSEcCtD
Doxazosin—Discomfort—Varenicline—nicotine dependence	0.00211	0.00292	CcSEcCtD
Doxazosin—Dry mouth—Varenicline—nicotine dependence	0.00209	0.00289	CcSEcCtD
Doxazosin—Oedema—Varenicline—nicotine dependence	0.00205	0.00283	CcSEcCtD
Doxazosin—Infection—Varenicline—nicotine dependence	0.00203	0.00282	CcSEcCtD
Doxazosin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00203	0.01	CbGpPWpGaD
Doxazosin—Shock—Varenicline—nicotine dependence	0.00201	0.00279	CcSEcCtD
Doxazosin—Thrombocytopenia—Varenicline—nicotine dependence	0.002	0.00278	CcSEcCtD
Doxazosin—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.002	0.00988	CbGpPWpGaD
Doxazosin—Tachycardia—Varenicline—nicotine dependence	0.002	0.00277	CcSEcCtD
Doxazosin—ADRA1A—brain—nicotine dependence	0.002	0.0266	CbGeAlD
Doxazosin—Skin disorder—Varenicline—nicotine dependence	0.00199	0.00275	CcSEcCtD
Doxazosin—Hyperhidrosis—Varenicline—nicotine dependence	0.00198	0.00274	CcSEcCtD
Doxazosin—ADRA1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00198	0.00975	CbGpPWpGaD
Doxazosin—Anorexia—Varenicline—nicotine dependence	0.00195	0.0027	CcSEcCtD
Doxazosin—KCNH2—brain—nicotine dependence	0.00193	0.0257	CbGeAlD
Doxazosin—Hypotension—Varenicline—nicotine dependence	0.00191	0.00265	CcSEcCtD
Doxazosin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00187	0.00921	CbGpPWpGaD
Doxazosin—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00187	0.00258	CcSEcCtD
Doxazosin—Insomnia—Varenicline—nicotine dependence	0.00185	0.00256	CcSEcCtD
Doxazosin—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00184	0.00908	CbGpPWpGaD
Doxazosin—ADRA2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00184	0.00906	CbGpPWpGaD
Doxazosin—Dyspnoea—Varenicline—nicotine dependence	0.00183	0.00253	CcSEcCtD
Doxazosin—Somnolence—Varenicline—nicotine dependence	0.00182	0.00252	CcSEcCtD
Doxazosin—Dyspepsia—Varenicline—nicotine dependence	0.0018	0.0025	CcSEcCtD
Doxazosin—Decreased appetite—Varenicline—nicotine dependence	0.00178	0.00246	CcSEcCtD
Doxazosin—Fatigue—Varenicline—nicotine dependence	0.00176	0.00244	CcSEcCtD
Doxazosin—Pain—Varenicline—nicotine dependence	0.00175	0.00242	CcSEcCtD
Doxazosin—Constipation—Varenicline—nicotine dependence	0.00175	0.00242	CcSEcCtD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00173	0.00853	CbGpPWpGaD
Doxazosin—ABCB1—cardiovascular system—nicotine dependence	0.00172	0.023	CbGeAlD
Doxazosin—KCNH2—Neuronal System—GABRA4—nicotine dependence	0.0017	0.00838	CbGpPWpGaD
Doxazosin—Feeling abnormal—Varenicline—nicotine dependence	0.00169	0.00234	CcSEcCtD
Doxazosin—Gastrointestinal pain—Varenicline—nicotine dependence	0.00167	0.00232	CcSEcCtD
Doxazosin—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00165	0.00811	CbGpPWpGaD
Doxazosin—KCNH2—Neuronal System—CHRNB4—nicotine dependence	0.00163	0.00803	CbGpPWpGaD
Doxazosin—Urticaria—Varenicline—nicotine dependence	0.00163	0.00225	CcSEcCtD
Doxazosin—Body temperature increased—Varenicline—nicotine dependence	0.00162	0.00224	CcSEcCtD
Doxazosin—Abdominal pain—Varenicline—nicotine dependence	0.00162	0.00224	CcSEcCtD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00157	0.00775	CbGpPWpGaD
Doxazosin—ADRA2A—brain—nicotine dependence	0.00152	0.0202	CbGeAlD
Doxazosin—KCNH2—Neuronal System—CHRNA5—nicotine dependence	0.00151	0.00747	CbGpPWpGaD
Doxazosin—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00151	0.00746	CbGpPWpGaD
Doxazosin—Hypersensitivity—Varenicline—nicotine dependence	0.00151	0.00209	CcSEcCtD
Doxazosin—ADRA2A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00149	0.00735	CbGpPWpGaD
Doxazosin—Asthenia—Varenicline—nicotine dependence	0.00147	0.00203	CcSEcCtD
Doxazosin—Pruritus—Varenicline—nicotine dependence	0.00145	0.00201	CcSEcCtD
Doxazosin—Diarrhoea—Varenicline—nicotine dependence	0.0014	0.00194	CcSEcCtD
Doxazosin—Dizziness—Varenicline—nicotine dependence	0.00135	0.00187	CcSEcCtD
Doxazosin—ABCB1—midbrain—nicotine dependence	0.00135	0.0179	CbGeAlD
Doxazosin—ADRA1D—GPCR ligand binding—TAS2R16—nicotine dependence	0.00132	0.0065	CbGpPWpGaD
Doxazosin—Vomiting—Varenicline—nicotine dependence	0.0013	0.0018	CcSEcCtD
Doxazosin—Rash—Varenicline—nicotine dependence	0.00129	0.00179	CcSEcCtD
Doxazosin—Dermatitis—Varenicline—nicotine dependence	0.00129	0.00179	CcSEcCtD
Doxazosin—Headache—Varenicline—nicotine dependence	0.00128	0.00178	CcSEcCtD
Doxazosin—KCNH2—Neuronal System—CHRNA3—nicotine dependence	0.00123	0.00609	CbGpPWpGaD
Doxazosin—Nausea—Varenicline—nicotine dependence	0.00122	0.00168	CcSEcCtD
Doxazosin—CYP2D6—brain—nicotine dependence	0.00118	0.0157	CbGeAlD
Doxazosin—ADRA1B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00109	0.0054	CbGpPWpGaD
Doxazosin—KCNH2—Neuronal System—CHRNB2—nicotine dependence	0.00109	0.00536	CbGpPWpGaD
Doxazosin—KCNH2—Neuronal System—CHRNA4—nicotine dependence	0.000987	0.00487	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000972	0.00479	CbGpPWpGaD
Doxazosin—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000927	0.00457	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000903	0.00445	CbGpPWpGaD
Doxazosin—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000874	0.00431	CbGpPWpGaD
Doxazosin—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000862	0.00425	CbGpPWpGaD
Doxazosin—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000853	0.00421	CbGpPWpGaD
Doxazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000852	0.0042	CbGpPWpGaD
Doxazosin—ABCB1—brain—nicotine dependence	0.000846	0.0113	CbGeAlD
Doxazosin—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000804	0.00396	CbGpPWpGaD
Doxazosin—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000793	0.00391	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000745	0.00367	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00073	0.0036	CbGpPWpGaD
Doxazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000707	0.00349	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.000677	0.00334	CbGpPWpGaD
Doxazosin—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000629	0.0031	CbGpPWpGaD
Doxazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000628	0.0031	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000618	0.00305	CbGpPWpGaD
Doxazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000616	0.00304	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000606	0.00299	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—FGD1—nicotine dependence	0.000585	0.00288	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000584	0.00288	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000562	0.00277	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—OPRM1—nicotine dependence	0.000556	0.00274	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000549	0.00271	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000538	0.00265	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—FGD1—nicotine dependence	0.000531	0.00262	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000528	0.0026	CbGpPWpGaD
Doxazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000511	0.00252	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00051	0.00252	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.0005	0.00247	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000499	0.00246	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.000485	0.00239	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000463	0.00229	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000461	0.00227	CbGpPWpGaD
Doxazosin—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000455	0.00224	CbGpPWpGaD
Doxazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000454	0.00224	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.000441	0.00217	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000438	0.00216	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000431	0.00213	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000422	0.00208	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.00041	0.00202	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—DRD2—nicotine dependence	0.000402	0.00198	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.0004	0.00197	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TAS2R16—nicotine dependence	0.0004	0.00197	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.000391	0.00193	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000389	0.00192	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000381	0.00188	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	0.000364	0.00179	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000361	0.00178	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	0.000334	0.00164	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000332	0.00164	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.000314	0.00155	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—FGD1—nicotine dependence	0.000314	0.00155	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000311	0.00154	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	0.000296	0.00146	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000295	0.00145	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—OPRM1—nicotine dependence	0.000285	0.00141	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AKR1B10—nicotine dependence	0.000277	0.00137	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	0.000275	0.00136	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000274	0.00135	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000261	0.00129	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	0.00026	0.00128	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	0.000237	0.00117	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000232	0.00114	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	0.000231	0.00114	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	0.00023	0.00113	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—DRD2—nicotine dependence	0.000227	0.00112	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000215	0.00106	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	0.000215	0.00106	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CYP2A7—nicotine dependence	0.000211	0.00104	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	0.00021	0.00104	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—DRD2—nicotine dependence	0.000206	0.00102	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	0.000204	0.00101	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	0.000195	0.000963	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—WASF2—nicotine dependence	0.000195	0.000962	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	0.00019	0.000936	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	0.000188	0.000929	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—WASF1—nicotine dependence	0.000187	0.000923	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	0.000171	0.000844	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—OPRM1—nicotine dependence	0.000168	0.000831	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	0.000167	0.000825	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	0.000162	0.000799	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000156	0.000767	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	0.000155	0.000766	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	0.000152	0.00075	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000149	0.000737	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000146	0.000719	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	0.000144	0.00071	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	0.000141	0.000696	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	0.00014	0.00069	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	0.000138	0.00068	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000137	0.000678	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	0.000134	0.000659	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	0.000128	0.000632	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	0.000124	0.000612	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—DRD2—nicotine dependence	0.000122	0.000601	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	0.000115	0.000569	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	0.000101	0.000499	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	8.98e-05	0.000443	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	8.34e-05	0.000411	CbGpPWpGaD
